Wellsheet

The acquisition leaves the product name open

Elsevier said Wellsheet would be integrated into its Clinical Solutions business. Terms were not disclosed, and the release does not say whether the Wellsheet name will continue. The homepage still sells under that name and carries the acquisition notice. Elsevier says Wellsheet is deployed at 139 hospital sites in the US.

Care Team Copilot drafts from the chart, per the homepage

The homepage calls the product "the only AI platform that unites chart summarization, documentation and clinical pathways." It says the views adapt to specialty, role and usage and that the agent is embedded in the EHR. In documentation, the homepage says the AI reads the full chart to draft the hospital course, the assessment and plan, and discharge summaries. For clinical pathways, it says the AI analyzes medications, labs and notes and shows the supporting chart evidence, and an "AI Pathways" agent navigates evidence-based pathways. The homepage also describes an AI chat in the EHR that answers clinician questions.

The company page adds a disclaimer that certain features described are illustrative of potential capabilities and are not currently included in the Wellsheet product.

Ascension quotes up to two hours saved a day

Ascension's announcement of October 15, 2025 says clinicians are saving up to two hours per day, and describes the product as summarizing patient information into one view and coordinating tasks among care team members. The vendor's own figures are 10,000-plus clinician users, 2 hours saved per clinician per day and a 50% cut in charting time.

No EHR is named

The homepage says the product is interoperable and cross-platform. Elsevier says it is integrated into major EHR systems, and the company page mentions partnerships with EHR vendors. A SOC 2 badge appears on the homepage with no type or date, and HIPAA, a BAA and HITRUST are not stated. No price is listed, and the homepage routes inquiries to a contact form.

A $3.8M Series A in 2020 is the documented round

A vendor post announces a $3.8M Series A on June 15, 2020, led by SpringTide Investments with BioAdvance and Newark Venture Partners, after $2.2M from angels and seed funds. The company page lists Springtide Investments, Newark Venture Partners, BioAdvance and Real Life Innovations as investors, and Craig Limoli as CEO and John Paul Patrizio as CTO. The 2020 release is datelined Newark, New Jersey. Founding in 2015 and a New York address come from data sites and are unverified.

The verdict

Elsevier's release gives 139 deployed hospital sites in the US and says the product is integrated into major EHR systems, yet neither the release nor Wellsheet's pages name one of those systems. The company page adds that some described features are illustrative and not in the current product, and it does not say which ones.